SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
68 hedge funds and large institutions have $124M invested in Syros Pharmaceuticals, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
Holders
68
Holding in Top 10
2
Calls
$85K
Puts
–
Top Buyers
| 1 | +$2.07M | |
| 2 | +$1.33M | |
| 3 | +$881K | |
| 4 |
Renaissance Technologies
New York
|
+$537K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$522K |
Top Sellers
| 1 | -$2.03M | |
| 2 | -$1.79M | |
| 3 | -$618K | |
| 4 |
Millennium Management
New York
|
-$427K |
| 5 |
VEA
Virtus ETF Advisers
New York
|
-$424K |